Guillaume G.
- Country
- Belgium
- Department
- Oncology
Research Overview
- Phase I/IIa Study of Inhaled CIS-DPI as Adjunctive Therapy in Stage IV Non-Small Cell Lung Cancer Patients
- Non-Inferiority Study of Pembrolizumab Maintenance Therapy at Standard vs. Reduced Dose in Metastatic Non-Squamous Lung Cancer
- A Phase 3 Study of JNJ-78278343 and Docetaxel Versus Docetaxel in Patients With Metastatic Castration-Resistant Prostate Cancer
Data & Insights
Has run more than one trial at 118 of 371 partner sites.
Specializations
Prostate Cancer Research
This investigator specializes in advanced prostate cancer treatments, with particular emphasis on biomarker-driven therapies and hormone-sensitive prostate cancer.
- Metastatic disease management
- Androgen deprivation therapy optimization
- PSMA PET imaging applications
Their research encompasses novel approaches to oligometastatic disease and biochemically recurrent prostate cancer.
Lung Cancer Studies
The investigator focuses on non-small cell lung cancer treatment, particularly in oligometastatic disease and innovative therapeutic approaches.
- Immunotherapy applications
- Maintenance therapy strategies
- Advanced stage disease management
Their work includes evaluation of targeted therapies and novel treatment combinations.
Renal Cancer Expertise
The investigator conducts research in metastatic renal cell carcinoma, with specific focus on diagnostic imaging and treatment response assessment.
- PSMA PET imaging evaluation
- Immunotherapy response prediction
- Treatment efficacy assessment
Their studies incorporate advanced imaging techniques for treatment monitoring.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.